Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Cello's Talking Taboos

19 Sep 2012 07:01

RNS Number : 5783M
Cello Group plc
19 September 2012
 



For Immediate Release

19 September 2012

 

Cello Group plc

("Cello", or "the Group")

 

 

Launch of Cello's Talking Taboos Results & Recommendations

 

Cello Group plc (AIM: CLL), the health focused insight and strategic marketing Group, is launching the results of its social responsibility programme 'Talking Taboos'.

 

Talking Taboos is a campaigning brand that aims to tackle health and social issues using Cello's experience and resources in the healthcare space. It will focus on areas where embarrassment, fear or ignorance prevents sufferers from seeking help.

 

On October 23 2012, Cello will reveal the results of a ground-breaking yearlong research study working in partnership with YoungMinds, the UK's leading children and young people's mental health and wellbeing charity. The research used a suite of services including advanced qualitative research, professional online community forums, social media discourse research integrated with a nationally representative quantitative sample of 2,500. It explores perceptions of young people who self-harm and whether they are receiving the help they so desperately need.

The study demonstrates Cello's expertise in the health sector and its commitment to stimulating discourse around pressing health and social issues. The Group has pooled its extensive knowledge and expertise with specific audiences, healthcare professionals, GP's, young people, teachers and parents to contribute to a 'whole community' view. In conjunction with YoungMinds, it will form the basis for a series of clear recommendations on how to relieve the suffering and distress experienced by those affected. Cello's communications team, led by Leith Group's Stripe Communications, will manage the media launch, targeting mainstream and health professional press as well as relevant online and social media channels. It will provide context for the growing national debate around self-harm and offer guidance and recommendations on how to better support those affected. The programme is being led by Vincent Nolan, Managing Partner of Cello Group and Founder of 2CV.

Mark Scott, Cello Group CEO, said:

 

"Talking Taboos is a great opportunity for us to show our ability to contribute to the wider social health debate by utilising our expertise in the Health sector and our market leading research and communications capabilities.

 

"It is also an ideal way for our companies to demonstrate their abilities and talents and work across the Group to deliver a comprehensive integrated project that will inform the way that self-harm is handled."

 

Enquiries:

 

Cello Group plc (www.cellogroup.com)

Mark Scott, Chief Executive

020 7812 8460

Vincent Nolan, Group Managing Partner

020 7655 9900

Cenkos

Bobbie Hilliam/Stephen Keys

020 7397 8900

Buchanan

Mark Edwards/Nicola Cronk/Clare Akhurst

020 7466 5000

 

 

 

Notes to Editors (www.cellogroup.com)

 

The launch event will be chaired by Claire Perry MP, at Portcullis House in the Houses of Parliament. For an invitation to the launch, or a copy of the report, contact talkingtaboos@stripecom.co.uk

About Cello

Cello is an insight and strategic marketing group.

The Group's strategy is to create value for shareholders by building an international marketing advisory business able to advise blue chip clients globally, with a primary focus on the pharmaceutical sector, along with other high margin client sectors.

Cello has annualised revenues in excess of £130m, annualised gross profit in excess of £65m and employs over 700 professional staff.

 

About YoungMinds

 

YoungMinds is the UK's leading charity committed to improving the emotional well-being and mental health of children and young people and empowering their parents and carers. Driven by their experiences we campaign, research and influence policy and practice. We also provide expert knowledge to professionals, parents and young people through our parents helpline, online resources, training and development, outreach work and publications. For further information visit www.youngminds.org.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFMGMLVRDGZZM
Date   Source Headline
6th Jul 20204:59 pmPRNForm 8.3 - Cello Health Plc
6th Jul 20203:45 pmRNSForm 8.3 - Cello Health plc
6th Jul 20203:13 pmRNSForm 8.3 - CELLO HEALTH PLC
6th Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
6th Jul 202012:15 pmRNSForm 8.3 - Cello Health Plc
6th Jul 20207:00 amRNSUpdate on irrevocable undertakings
3rd Jul 20203:20 pmRNSForm 8.3 - Cello Health
3rd Jul 20203:16 pmRNSForm 8.3 - CELLO HEALTH PLC
3rd Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
3rd Jul 20202:30 pmRNSForm 8.3 - Cello Health PLC
3rd Jul 202011:53 amRNSForm 8.3 - Cello Health Plc
3rd Jul 20209:36 amRNSForm 8.3 - Cello Health Plc
3rd Jul 20207:00 amRNSReplacement - Form 8 (OPD) - Cello Health plc
3rd Jul 20207:00 amRNSForm 8.3 - Cello Health PLC
2nd Jul 20206:26 pmRNSForm 8.3 - Cello Health plc
2nd Jul 20203:20 pmRNSForm 8.3 - Cello Health
2nd Jul 20202:29 pmRNSForm 8.3 - CELLO GROUP PLC
2nd Jul 20201:07 pmRNSForm 8.3 - Cello Health Plc
2nd Jul 202012:17 pmRNSForm 8.3 - Cello Health Plc
2nd Jul 202010:57 amRNSForm 8.3 - CELLO HEALTH PLC
2nd Jul 202010:26 amGNWForm 8.3 - [Cello Health plc - Opening Declaration] - (HH Ltd)
2nd Jul 202010:25 amRNSForm 8.3 - Cello Health Plc
2nd Jul 20208:53 amRNSForm 8.5 (EPT/NON-RI)
2nd Jul 20207:00 amRNSUpdate on letters of intent
2nd Jul 20207:00 amRNSForm 8 (OPD) - Cello Health plc
1st Jul 20205:21 pmGNWForm 8.3 - Cello Health plc
1st Jul 20203:31 pmPRNForm 8.3 - Cello Health
1st Jul 20209:05 amRNSForm 8.3 - Cello Health plc
1st Jul 20207:00 amRNSRECOMMENDED CASH OFFER
15th Jun 202010:09 amRNSHolding(s) in Company
11th Jun 20203:48 pmRNSHolding(s) in Company
20th May 20201:05 pmRNSResult of AGM
20th May 20207:00 amRNSAGM Statement
5th May 20207:00 amRNSIssue of Equity
21st Apr 20207:00 amRNSAnnual Report and Notice of AGM
17th Apr 20209:46 amRNSTotal Voting Rights
14th Apr 20205:18 pmRNSHolding(s) in Company
7th Apr 20207:00 amRNSCOVID-19 Update
30th Mar 20209:37 amRNSGrant of Options
18th Mar 20207:00 amRNSPreliminary Results
7th Feb 202012:19 pmRNSHolding(s) in Company
6th Feb 20207:00 amRNSSettlement with Access Intelligence
22nd Jan 20204:40 pmRNSBlock listing Interim Review
16th Jan 20207:00 amRNSPre-Close Trading Statement
3rd Dec 20193:09 pmRNSTotal Voting Rights
22nd Nov 20194:55 pmRNSHolding(s) in Company
14th Nov 20199:30 amRNSHolding(s) in Company
13th Nov 20195:00 pmRNSTotal Voting Rights
7th Oct 20191:39 pmRNSHolding(s) in Company
7th Oct 20191:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.